# JMS Healthcare PHL Inc. – FDA Inspection, May 12, 2023

Source: https://www.keypedia.com/records/fda_inspections/jms-healthcare-phl-inc/27432494-091b-42ad-a12d-e9fdda166154
Source feed: FDA_Inspections

> FDA inspection 1205507 of JMS Healthcare PHL Inc., May 12, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 820. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205507
- Company Name: JMS Healthcare PHL Inc.
- Inspection Date: 2023-05-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Officers

- [Company Rep](https://www.keypedia.com/people/brandon-l-mariner/c1ff0e66-552d-466a-9b49-a083d0211c94)
- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/jms-healthcare-phl-inc/3851d071-2d1b-4f80-87c2-76512ba8f84b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
